11 Things to Know About Protara Therapeutics as TARA Stock Soars on Big FDA News
Protara Therapeutics (NASDAQ:TARA) stock is heading higher on Tuesday following some major news from the U.S. Food and Drug Administration (FDA).
Source: CI Photos / Shutterstock.com
Let’s dive into that news below, as well as cover what else investors need to know about Protara Therapeutics.
Today’s big news is the FDA . TARA-002 is an investigational cell-based therapy in development to treat non-muscle invasive bladder cancer (NMIBC). Approval from the FDA means that Pro...